MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/03/2019 31/08/2024 Topic: Training Project type: Preclinic Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Participating agents: UNIVERSITA CATTOLICA DEL SACRO CUORE Keywords: big data; AI; training; network; education; technology; policy; e-health Countries: Italy; Germany; Netherlands; Slovenia; UK; Belgium; Spain...

Dates: 01/01/2021 30/06/2026 Topic: Tool Project type: Theranostic Preclinic Project target: Cancer Neurology Financing: H2020-EU.4.c. – Establishing ‚ERA Chairs’ Participating agents: INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA Keywords: medical technology; nanotechnology; oncology; infection; neurodegenerative; tissue; molecular bioengineering; therapy Countries: Portugal Project page: Access page  

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Prostate Cancer Colorectal Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: reinforcement; drug resistance; colorectal cancer; prostate cancer; oncology; monotherapy; HTS Countries: Germany Project page: Access page...

Dates: 01/04/2018 30/09/2024 Topic: AI/Big data Project type: Preclinic Theranostic Project target: Cancer Infectious disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: BARCELONA SUPERCOMPUTING CENTER-CENTRO NACIONAL DE SUPERCOMPUTACION UNIVERSITY COLLEGE LONDON Keywords: big data; mathematical model; biomarker; NMTF; non-negative matrix tri-factorization; covid-19; cancer; OMICs; Countries: Spain; UK Project page: Access...

Dates: 01/01/2019 31/05/2023 Topic: Tool AI/Big Data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5.3. – Using in-silico medicine for improving disease management and prediction Other Participating agents: TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH Keywords: paediatric; oncology; big data; cancer; machine learning; stadistics; tumour; clinical...

Dates: 01/01/2020 31/12/2024 Topic: Tool AI/Big Data Project type: Preclinic Project target: Endocrine disease Cardiovascular disease Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Other Participating agents: BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM Keywords: critical care medicine; personalized medicine; productivity; in-silico; model; virtual reality Countries:...

Dates: 01/10/2020 30/09/2023 Topic: AI/Big data Procedures Project type: Preclinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITEIT MAASTRICHT Keywords: machine learning; coronavirus; diagnosis; prognosis; molecular profiling; multidata; therapeutic Countries: Netherlands; Belgium; UK; Italy; Switzerland Project page:...

Dates: 22/03/2021 21/03/2024 Topic: Tool Project type: Preclinic Theranostic Project target: Ovarian Cancer Financing: H2020-EU.1.3.2. – Nurturing excellence by means of cross-border and cross-sector mobility Participating agents: DUBLIN CITY UNIVERSITY -COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH Keywords: synthetic biology; tissue engineering; transition metals; oncology; screening; drug resistance; theranostic Countries: Ireland; South Africa Project page: Access...

Dates: 01/02/2018 31/07/2023 Topic: Tool AI/Big Data Project type: Preclinic Project target: Neurology Cardiovascular disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5. – Methods and data Participating agents: UNIVERSITEIT MAASTRICHT Keywords: drug repurposing; biomarker; cerebro-cardiovascular; in-silico; clinical trial; efficacy Countries: Denmark; UK; Germany; Netherlands; Austria Project page: Access page